SEC Form 4 · accession 0001225208-15-003523
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willie A Deese
Officer — Exe V-P & Pres. MMD
Period of report
Feb 11, 2015
Accepted (ET)
Feb 11, 2015 · 2:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 11, 2015 | M | 53,040 | $44.30 | A | 159,270 | D | |
| Common Stock | Feb 11, 2015 | M | 48,144 | $33.49 | A | 207,414 | D | |
| Common Stock | Feb 11, 2015 | M | 34,680 | $44.19 | A | 242,094 | D | |
| Common StockF1,F2 | Feb 11, 2015 | S | 135,864 | $58.5613 | D | 106,230 | D | |
| Common Stock - 401(k) PlanF3 | holding | — | — | — | 695 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $44.30 | Feb 11, 2015 | M | 53,040 | D | Feb 28, 2009 | Feb 28, 2018 | Common Stock | 53,040 | 0 | D |
| Stock Option (right to buy)F5 | $44.19 | Feb 11, 2015 | M | 34,680 | D | Mar 2, 2008 | Mar 1, 2017 | Common Stock | 34,680 | 0 | D |
| Stock Option (right to buy)F6 | $33.49 | Feb 11, 2015 | M | 48,144 | D | May 7, 2011 | May 6, 2020 | Common Stock | 48,144 | 8,346 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.4000 to $58.7900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- F2Holdings include shares acquired in dividend reinvestment transactions.
- F3Includes shares acquired and dividends earned through January 8, 2015, in the Merck U.S. Savings Plan, a 401(k) plan.
- F4The option became exercisable in equal installments on 2/28/2009, 2/28/2010 and 2/28/2011.
- F5The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.
- F6The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.